| Literature DB >> 30559878 |
Svetlan Dermendzhiev1, Mariya Ivanovska2,3, Tihomir Dermendzhiev2.
Abstract
BACKGROUND: Allergic contact dermatitis (ACD) is common in clinical practice, but the aetiology of this disease is quite varied. A leading pathogenetic mechanism is a cell-mediated immunity. The combinations of ACD with other allergic and systemic autoimmune diseases are relatively rare, but these conditions are undoubtedly a professional challenge for practitioners. CASE REPORT: We present a case of ACD combined with other immune-allergic conditions. Aetiology and pathogenesis in these cases are not well understood.Entities:
Keywords: Angioneurotic oedema; Autoimmune thrombocytopenia; Conjunctivitis; Contact dermatitis
Year: 2018 PMID: 30559878 PMCID: PMC6290415 DOI: 10.3889/oamjms.2018.447
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Haematological and biochemical tests
| Haematology | Differential blood count | Biochemistry |
|---|---|---|
| НGB – 136 g/l | Neut. – 77.4 % | gluc – 5.1 mmol/l |
| RBC – 4.66 T/l | Lymph. – 16.5 % | t.prot – 70.0 g/l |
| HCT – 0.397 pg/l | Eos. – 0.1 % | alb – 45.0 g/l |
| MCH – 29.1 pg | Mono – 4.4 % | urea – 3.3 mmol/l |
| MCV – 85 fl | Baso – 0.3 % | crea – 78 mmol/l |
| WBC – 8.74 G/l | AST – 16 u/l | |
| ALT – 22 u/l | ||
| PLT – 153 G/l | ||
| ESR – 22 mm/h |
ANA profile3 (14Ag, PCNA)
| Antigen | Method | Result |
|---|---|---|
| immunoblot | +++ | |
| SS-A native (60kDa) | immunoblot | + |
| Ro-52 recombinant | immunoblot | ++ |
| Nucleosomes | immunoblot | + |
| Histones | immunoblot | 0 |
| Sm | immunoblot | 0 |
Figure 1Maculopapular rash behind ears and neck
Figure 2Rash on the upper body
Skin-allergic samples with a panel of plant and animal allergens
| Grass | 20 min | Micro ticks | 20 min |
|---|---|---|---|
| 688 (5 kinds of grass) | ( - ) | 314 (D. farinae) | ( - ) |
| 687 (4 wheat) | ( - ) | 315 (D. pteronissimus) | ( - ) |
| Trees | Allergens of animal origin | ||
| 696 (Beech) | ( - ) | 507 (Cat) | ( - ) |
| 702 (Birch) | 509 (Dog) | ( - ) | |
| 701 (Willow) | ( - ) | 506 (Feathers) | ( - ) |
| Weeds | Controls | ||
| 604 (Ambrosia) | ( - ) | Positive control (histamine) | 8/5 |
| 605 (Plain wormwwod) | ( - ) | Negative control | ( - ) |
| 665 (Plantain) | ( - ) | ||
| 714 (Atripliceae) | ( - ) |
Epicutaneous test with European standard series for epicutaneous testing (European Environmental and Contact Dermatitis Research Group)
| No | |||
|---|---|---|---|
| 1 | Potassium dichromate | - | - |
| 2 | 4-phenylenediamine base (PPD) | - | - |
| 3 | Thiuram mix | - | - |
| 4 | Neomycin sulfate | - | - |
| 5 | Cobalt (||) chloride hexahydrate | - | - |
| 6 | Benzocaine | - | - |
| 7 | Nickel sulfate hexahydrate | - | - |
| 8 | Clioquinol | - | - |
| 9 | Colophony | + + | + |
| 10 | Paraben mix | + + + | + + |
| 11 | N-lsopropyl-N-phenyl-3-phenylenediamine (IPPD) | - | - |
| 12 | Lanolin Alcohol | + + | + |
| 13 | Mercapto mix | - | - |
| 14 | Epoxy resin | - | - |
| 15 | Balsam Peru | - | - |
| 16 | 4-tert-Butylphenolformaldehyde resin | - | - |
| 17 | 2-Mercaptobenzothiazole (MBT) | - | - |
| 18 | Formaldehyde | - | - |
| 19 | Fragrance mix I | + + + | + + |
| 20 | Sesquiterpene lactone mix | - | - |
| 21 | Qua ternium 15 | - | - |
| 22 | 2-methoxy-6-n-pentyl-4-benzoquinone (Primin) | - | - |
| 23 | 5-chloro-2-methyl-4-isothiazolin-3-one (Kathon CG) | - | - |
| 24 | Budesonide | - | - |
| 25 | Tixocortol-21-pivalate | - | - |
| 26 | Methyldibromoglutaronitrile | - | - |
| 27 | Fragrance mix || | - | - |
| 28 | Lyral (alfa-hexyl cinnamal) | + + + | + + |
Scale for interpretation of Immunoblot
| Intensity | Class | explanation |
|---|---|---|
| 0-5 | 0 | negative |
| 6-10 | ( + ) | borderline |
| 11-25 | ( + ) | positive |
| 26-50 | ( ++ ) | strong positive |
| 51-256 | ( +++ ) | strong positive |
Immunological parameters
| Test | Method | Result | Reference value |
|---|---|---|---|
| Tot. IgE | ELISA | 12 IU/ml | 0 – 100 IU/ml |
| C 3 | nephelometry | 1.44 g/l | 0.9 – 1.8 g/l |
| C 4 | nephelometry | 0.18 g/l | 0.1 – 0.4 g/l |
| C1 esterase inhibitor (Ag) | RID | 31.2 mg/dl | sera 21.0 – 39 mg/dl plasma 18.0–32 mg/dl |
| C1esterase inhibitor (func) | 113 % | 70 – 130 % |